AquaVac® PD3, Emulsion for injection, for Atlantic salmon
AQUAVAC PD3 is a trivalent vaccine (0.1 ml dose) containing inactivated Salmon pancreas disease virus (SPDV) strain F93-125, Infectious Pancreatic Necrosis virus (IPNV) and Aeromonas salmonicida.
Presentation
White to nearly white emulsion for injection
Active ingredients
Salmon pancreas disease virus (SPDV) strain F93-125, ≥ 75 % RPP1
Infectious pancreatic necrosis virus (IPNV), ≥ 1.5 ELISA units2
Aeromonas salmonicida subsp. salmonicida, ≥ 80 % RPS603
1 RPP: relative percentage protection in a laboratory test in Atlantic salmon
2 Antigenic mass measured in the final product
3 RPS: relative percentage survival at 60 % control mortality in a laboratory test in Atlantic salmon
Target species
Atlantic salmon (Salmo salar L)
Indications for use
For active immunisation of Atlantic salmon to reduce clinical signs (heart lesions and pancreas lesions), viremia, viral shedding and mortality from infection with SPDV (Pancreas disease) and to reduce mortality from infections with IPNV (Infectious pancreatic necrosis) and Aeromonas salmonicida subsp. salmonicida (furunculosis).
Immunity onset is 500 degree days after vaccination for SPDV and Aeromonas salmonicida and 540 degree days after vaccination for IPNV.
Duration of immunity has been demonstrated at 15 months post vaccination for SPDV and at 16 months post vaccination for Aeromonas salmonicida. Protection against mortality due to IPNV infection has been demonstrated at 4 months post vaccination in the field.
Withdrawal periods
Zero degree days
Packaging
Bottles of polyethylene terephthalate (PET) closed with a rubber stopper and aluminium cap. Package size: 500 ml (5,000 doses).
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Date of preparation: September 2023